LY 053857Alternative Names: LY 53857
Latest Information Update: 30 Jul 2002
At a glance
- Originator Eli Lilly
- Class Anti-ischaemics; Antihypertensives; Antimigraines; Ergolines; Small molecules
- Mechanism of Action Serotonin 2 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Ischaemic heart disorders; Migraine; Thrombosis